Product Code:158004
Published Date: Jun 05,2021
Pages: 87
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
According to this latest study, the 2021 growth of Injectable Anticoagulants will have significant change from previous year. By the most conservative estimates of global Injectable Anticoagulants market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 5815.7 million in 2020. Over the next five years the Injectable Anticoagulants market will register a 2.2% CAGR in terms of revenue, the global market size will reach US$ 6339.3 million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Injectable Anticoagulants market by product type, application, key players and key regions and countries. Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7. Low-Molecular-Weight Heparin (LMWH) Direct Thrombin Inhibitor (DTI) Others Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8. VTE ACS/MI AF Others This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8. Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3. Sanofi Genentech (Roche) Boehringer Ingelheim Pfizer The Medicines Company Aspen Otsuka
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injectable Anticoagulants Market Size 2016-2026
2.1.2 Injectable Anticoagulants Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Injectable Anticoagulants Segment by Type
2.2.1 Low-Molecular-Weight Heparin (LMWH)
2.2.2 Low-Molecular-Weight Heparin (LMWH)
2.2.3 Others
2.3 Injectable Anticoagulants Market Size by Type
2.3.1 Global Injectable Anticoagulants Market Size CAGR by Type
2.3.2 Global Injectable Anticoagulants Market Size Market Share by Type (2016-2021)
2.4 Injectable Anticoagulants Segment by Application
2.4.1 VTE
2.4.2 ACS/MI
2.4.3 AF
2.4.4 Others
2.5 Injectable Anticoagulants Market Size by Application
2.5.1 Global Injectable Anticoagulants Market Size CAGR by Application
2.5.2 Global Injectable Anticoagulants Market Size Market Share by Application (2016-2021)
3 Injectable Anticoagulants Market Size by Players
3.1 Injectable Anticoagulants Market Size Market Share by Players
3.1.1 Global Injectable Anticoagulants Revenue by Players (2019-2021E)
3.1.2 Global Injectable Anticoagulants Revenue Market Share by Players (2019-2021E)
3.2 Global Injectable Anticoagulants Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Injectable Anticoagulants by Regions
4.1 Injectable Anticoagulants Market Size by Regions (2016-2021)
4.2 Americas Injectable Anticoagulants Market Size Growth (2016-2021)
4.3 APAC Injectable Anticoagulants Market Size Growth (2016-2021)
4.4 Europe Injectable Anticoagulants Market Size Growth (2016-2021)
4.5 Middle East & Africa Injectable Anticoagulants Market Size Growth (2016-2021)
5 Americas
5.1 Americas Injectable Anticoagulants Market Size by Country (2016-2021)
5.2 Americas Injectable Anticoagulants Market Size by Type (2016-2021)
5.3 Americas Injectable Anticoagulants Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injectable Anticoagulants Market Size by Region (2016-2021)
6.2 APAC Injectable Anticoagulants Market Size by Type (2016-2021)
6.3 APAC Injectable Anticoagulants Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Injectable Anticoagulants by Country (2016-2021)
7.2 Europe Injectable Anticoagulants Market Size by Type (2016-2021)
7.3 Europe Injectable Anticoagulants Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Injectable Anticoagulants by Region (2016-2021)
8.2 Middle East & Africa Injectable Anticoagulants Market Size by Type (2016-2021)
8.3 Middle East & Africa Injectable Anticoagulants Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Injectable Anticoagulants Market Forecast
10.1 Global Injectable Anticoagulants Forecast by Regions (2021-2026)
10.1.1 Global Injectable Anticoagulants Forecast by Regions (2021-2026)
10.1.2 Americas Injectable Anticoagulants Forecast
10.1.3 APAC Injectable Anticoagulants Forecast
10.1.4 Europe Injectable Anticoagulants Forecast
10.1.5 Middle East & Africa Injectable Anticoagulants Forecast
10.2 Americas Injectable Anticoagulants Forecast by Countries (2021-2026)
10.2.1 United States Injectable Anticoagulants Market Forecast
10.2.2 Canada Injectable Anticoagulants Market Forecast
10.2.3 Mexico Injectable Anticoagulants Market Forecast
10.2.4 Brazil Injectable Anticoagulants Market Forecast
10.3 APAC Injectable Anticoagulants Forecast by Region (2021-2026)
10.3.1 China Injectable Anticoagulants Market Forecast
10.3.2 Japan Injectable Anticoagulants Market Forecast
10.3.3 Korea Injectable Anticoagulants Market Forecast
10.3.4 Southeast Asia Injectable Anticoagulants Market Forecast
10.3.5 India Injectable Anticoagulants Market Forecast
10.3.6 Australia Injectable Anticoagulants Market Forecast
10.4 Europe Injectable Anticoagulants Forecast by Country (2021-2026)
10.4.1 Germany Injectable Anticoagulants Market Forecast
10.4.2 France Injectable Anticoagulants Market Forecast
10.4.3 UK Injectable Anticoagulants Market Forecast
10.4.4 Italy Injectable Anticoagulants Market Forecast
10.4.5 Russia Injectable Anticoagulants Market Forecast
10.5 Middle East & Africa Injectable Anticoagulants Forecast by Region (2021-2026)
10.5.1 Egypt Injectable Anticoagulants Market Forecast
10.5.2 South Africa Injectable Anticoagulants Market Forecast
10.5.3 Israel Injectable Anticoagulants Market Forecast
10.5.4 Turkey Injectable Anticoagulants Market Forecast
10.5.5 GCC Countries Injectable Anticoagulants Market Forecast
10.6 Global Injectable Anticoagulants Forecast by Type (2021-2026)
10.7 Global Injectable Anticoagulants Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Injectable Anticoagulants Product Offered
11.1.3 Sanofi Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Sanofi Main Business Overview
11.1.5 Sanofi Latest Developments
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Company Information
11.2.2 Genentech (Roche) Injectable Anticoagulants Product Offered
11.2.3 Genentech (Roche) Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Genentech (Roche) Main Business Overview
11.2.5 Genentech (Roche) Latest Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Injectable Anticoagulants Product Offered
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Boehringer Ingelheim Main Business Overview
11.3.5 Boehringer Ingelheim Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Injectable Anticoagulants Product Offered
11.4.3 Pfizer Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Company Information
11.5.2 The Medicines Company Injectable Anticoagulants Product Offered
11.5.3 The Medicines Company Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 The Medicines Company Main Business Overview
11.5.5 The Medicines Company Latest Developments
11.6 Aspen
11.6.1 Aspen Company Information
11.6.2 Aspen Injectable Anticoagulants Product Offered
11.6.3 Aspen Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Aspen Main Business Overview
11.6.5 Aspen Latest Developments
11.7 Otsuka
11.7.1 Otsuka Company Information
11.7.2 Otsuka Injectable Anticoagulants Product Offered
11.7.3 Otsuka Injectable Anticoagulants Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Otsuka Main Business Overview
11.7.5 Otsuka Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Injectable Anticoagulants Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Low-Molecular-Weight Heparin (LMWH) Table 3. Major Players of Direct Thrombin Inhibitor (DTI) Table 4. Major Players of Others Table 5. Injectable Anticoagulants Market Size CAGR by Type (2020-2026) & ($ Millions) Table 6. Global Injectable Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 7. Global Injectable Anticoagulants Market Size Market Share by Type (2016-2021) Table 8. Injectable Anticoagulants Market Size CAGR by Application (2016-2021) & ($ Millions) Table 9. Global Injectable Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 10. Global Injectable Anticoagulants Market Size Market Share by Application (2016-2021) Table 11. Global Injectable Anticoagulants Revenue by Players (2019-2021E) & ($ Millions) Table 12. Global Injectable Anticoagulants Revenue Market Share by Players (2019-2021E) Table 13. Injectable Anticoagulants Key Players Head office and Products Offered Table 14. Injectable Anticoagulants Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 15. New Products and Potential Entrants Table 16. Mergers & Acquisitions, Expansion Table 17. Global Injectable Anticoagulants Market Size by Regions 2016-2021 & ($ Millions) Table 18. Global Injectable Anticoagulants Market Size Market Share by Regions 2016-2021 Table 19. Americas Injectable Anticoagulants Market Size by Country (2016-2021) & ($ Millions) Table 20. Americas Injectable Anticoagulants Market Size Market Share by Country (2016-2021) Table 21. Americas Injectable Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 22. Americas Injectable Anticoagulants Market Size Market Share by Type (2016-2021) Table 23. Americas Injectable Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 24. Americas Injectable Anticoagulants Market Size Market Share by Application (2016-2021) Table 25. APAC Injectable Anticoagulants Market Size by Region (2016-2021) & ($ Millions) Table 26. APAC Injectable Anticoagulants Market Size Market Share by Region (2016-2021) Table 27. APAC Injectable Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 28. APAC Injectable Anticoagulants Market Size Market Share by Type (2016-2021) Table 29. APAC Injectable Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 30. APAC Injectable Anticoagulants Market Size Market Share by Application (2016-2021) Table 31. Europe Injectable Anticoagulants Market Size by Country (2016-2021) & ($ Millions) Table 32. Europe Injectable Anticoagulants Market Size Market Share by Country (2016-2021) Table 33. Europe Injectable Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 34. Europe Injectable Anticoagulants Market Size Market Share by Type (2016-2021) Table 35. Europe Injectable Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 36. Europe Injectable Anticoagulants Market Size Market Share by Application (2016-2021) Table 37. Middle East & Africa Injectable Anticoagulants Market Size by Region (2016-2021) & ($ Millions) Table 38. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Region (2016-2021) Table 39. Middle East & Africa Injectable Anticoagulants Market Size by Type (2016-2021) & ($ Millions) Table 40. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Type (2016-2021) Table 41. Middle East & Africa Injectable Anticoagulants Market Size by Application (2016-2021) & ($ Millions) Table 42. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Application (2016-2021) Table 43. Key and Potential Regions of Injectable Anticoagulants Table 44. Key Application and Potential Industries of Injectable Anticoagulants Table 45. Key Challenges of Injectable Anticoagulants Table 46. Key Trends of Injectable Anticoagulants Table 47. Global Injectable Anticoagulants Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 48. Global Injectable Anticoagulants Market Size Market Share Forecast by Regions (2021-2026) Table 49. Global Injectable Anticoagulants Market Size Forecast by Type (2021-2026) & ($ Millions) Table 50. Global Injectable Anticoagulants Market Size Market Share Forecast by Type (2021-2026) Table 51. Global Injectable Anticoagulants Market Size Forecast by Application (2021-2026) & ($ Millions) Table 52. Global Injectable Anticoagulants Market Size Market Share Forecast by Application (2021-2026) Table 53. Sanofi Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors Table 54. Sanofi Injectable Anticoagulants Product Offered Table 55. Sanofi Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 56. Sanofi Main Business Table 57. Sanofi Latest Developments Table 58. Genentech (Roche) Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors Table 59. Genentech (Roche) Injectable Anticoagulants Product Offered Table 60. Genentech (Roche) Main Business Table 61. Genentech (Roche) Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 62. Genentech (Roche) Latest Developments Table 63. Boehringer Ingelheim Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors Table 64. Boehringer Ingelheim Injectable Anticoagulants Product Offered Table 65. Boehringer Ingelheim Main Business Table 66. Boehringer Ingelheim Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 67. Boehringer Ingelheim Latest Developments Table 68. Pfizer Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors Table 69. Pfizer Injectable Anticoagulants Product Offered Table 70. Pfizer Main Business Table 71. Pfizer Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 72. Pfizer Latest Developments Table 73. The Medicines Company Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors Table 74. The Medicines Company Injectable Anticoagulants Product Offered Table 75. The Medicines Company Main Business Table 76. The Medicines Company Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 77. The Medicines Company Latest Developments Table 78. Aspen Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors Table 79. Aspen Injectable Anticoagulants Product Offered Table 80. Aspen Main Business Table 81. Aspen Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 82. Aspen Latest Developments Table 83. Otsuka Details, Company Type, Injectable Anticoagulants Area Served and Its Competitors Table 84. Otsuka Injectable Anticoagulants Product Offered Table 85. Otsuka Main Business Table 86. Otsuka Injectable Anticoagulants Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 87. Otsuka Latest Developments List of Figures Figure 1. Injectable Anticoagulants Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Injectable Anticoagulants Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Injectable Anticoagulants Market Size Market Share by Type in 2020 Figure 7. Injectable Anticoagulants in VTE Figure 8. Global Injectable Anticoagulants Market: VTE (2016-2021) & ($ Millions) Figure 9. Injectable Anticoagulants in ACS/MI Figure 10. Global Injectable Anticoagulants Market: ACS/MI (2016-2021) & ($ Millions) Figure 11. Injectable Anticoagulants in AF Figure 12. Global Injectable Anticoagulants Market: AF (2016-2021) & ($ Millions) Figure 13. Injectable Anticoagulants in Others Figure 14. Global Injectable Anticoagulants Market: Others (2016-2021) & ($ Millions) Figure 15. Global Injectable Anticoagulants Market Size Market Share by Application in 2020 Figure 16. Global Injectable Anticoagulants Revenue Market Share by Player in 2020 Figure 17. Global Injectable Anticoagulants Market Size Market Share by Regions (2016-2021) Figure 18. Americas Injectable Anticoagulants Market Size 2016-2021 ($ Millions) Figure 19. APAC Injectable Anticoagulants Market Size 2016-2021 ($ Millions) Figure 20. Europe Injectable Anticoagulants Market Size 2016-2021 ($ Millions) Figure 21. Middle East & Africa Injectable Anticoagulants Market Size 2016-2021 ($ Millions) Figure 22. Americas Injectable Anticoagulants Market Size Market Share by Country in 2020 Figure 23. Americas Injectable Anticoagulants Market Size Market Share by Type in 2020 Figure 24. Americas Injectable Anticoagulants Market Size Market Share by Application in 2020 Figure 25. United States Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 26. Canada Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 27. Mexico Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 28. APAC Injectable Anticoagulants Market Size Market Share by Regions in 2020 Figure 29. APAC Injectable Anticoagulants Market Size Market Share by Type in 2020 Figure 30. APAC Injectable Anticoagulants Market Size Market Share by Application in 2020 Figure 31. China Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 32. Japan Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 33. Korea Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 34. Southeast Asia Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 35. India Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 36. Australia Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 37. Europe Injectable Anticoagulants Market Size Market Share by Country in 2020 Figure 38. Europe Injectable Anticoagulants Market Size Market Share by Type in 2020 Figure 39. Europe Injectable Anticoagulants Market Size Market Share by Application in 2020 Figure 40. Germany Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 41. France Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 42. UK Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 43. Italy Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 44. Russia Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 45. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Region in 2020 Figure 46. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Type in 2020 Figure 47. Middle East & Africa Injectable Anticoagulants Market Size Market Share by Application in 2020 Figure 48. Egypt Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 49. South Africa Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 50. Israel Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 51. Turkey Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 52. GCC Country Injectable Anticoagulants Market Size Growth 2016-2021 ($ Millions) Figure 53. Americas Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 54. APAC Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 55. Europe Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 56. Middle East & Africa Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 57. United States Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 58. Canada Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 59. Mexico Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 60. Brazil Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 61. China Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 62. Japan Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 63. Korea Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 64. Southeast Asia Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 65. India Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 66. Australia Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 67. Germany Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 68. France Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 69. UK Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 70. Italy Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 71. Russia Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 72. Spain Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 73. Egypt Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 74. South Africa Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 75. Israel Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 76. Turkey Injectable Anticoagulants Market Size 2021-2026 ($ Millions) Figure 77. GCC Country Injectable Anticoagulants Market Size 2021-2026 ($ Millions)
Sanofi Genentech (Roche) Boehringer Ingelheim Pfizer The Medicines Company Aspen Otsuka
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Jan
2024
According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period.
$3660.00